Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
September 29, 2017
|
| |
| | | Members of the Georgia CTSA are jointly applying for an NIH center grant that will fund investigators to conduct clinical needs assessments for, technologically refine, and clinically validate novel point-of-care (POC) microsystems-based diagnostics specifically for cardiac, pulmonary, hematologic and/or sleep disorders.
Accordingly, if you are developing a POC microsystems technology designed to detect, prevent, or treat heart, lung, blood and/or ... | | | | Read More | | |
| |
| |  | | After a decade of research collaboration, the Atlanta Clinical & Translational Science Institute (ACTSI) will welcome a new partner and change its name, reflecting a new statewide focus. The University of Georgia will officially become the fourth academic partner and ACTSI will now be known as the Georgia Clinical & Translational Science Alliance (Georgia CTSA). This alliance is celebrating 10 years of research advancement by expanding across the ... | | | | Read More | | |
| |
| | | | The program is part of the Engineering Biology and Health cluster, which includes also Cellular and Biochemical Engineering; Biophotonics; Nano-Biosensing; and Disability and Rehabilitation Engineering.The goal of the EBMS program is to provide research opportunities to develop novel ideas into discovery-level and transformative projects that integrate engineering and life sciences in solving biomedical problems that serve humanity in the long-term. | | | | Read More | | |
| |
| | | | The purpose of this FOA is to support an ancillary study grant application(s) to add psychological, behavioral, and/or neurocognitive assessments to the data collection in adults enrolled at the clinical sites in the Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC) supported by the NIH Common Fund. | | | | Read More | | |
| |
| | | | The U.S. Department of Health and Human Services, Health Resources and Services Administration solicits applications. The RWHAP Part A program funds provide direct financial assistance to an eligible metropolitan area or a transitional grant area that has been severely affected by the HIV epidemic | | | | Read More | | |
| |
| | | | Supported by the NIH Common Fund Science of Behavior Change (SOBC) Program, this FOA solicits exploratory and developmental research project applications that will further the goal of the SOBC Program to advance a mechanisms-focused, experimental medicine approach to behavior change research. | | | | Read More | | |
| |
| | | | This FOA will solicit research projects focused on the development of new technology and tools, or novel mechanistic studies, or a combination of mechanistic and technology development studies specific to central nervous system small blood and lymphatic vessels in health and disease, across the life span. | | | | Read More | | |
| |
| | | | The overarching goal of the specialized Udall Centers program is to establish a network of centers that work collaboratively as well as independently to define the causes of and discover improved treatments for Parkinson's disease. | | | | Read More | | |
| |
| | | | Emory's Provost's Office and Emory¿s Woodruff Health Sciences Center (WHSC) announce a special cycle of Synergy II Awards to support new collaborative research projects between the faculty of the WHSC and the faculty of the Emory College of Arts and Sciences (ECAS). This announcement seeks proposals for novel research projects co-led by faculty of the WHSC and faculty of the ECAS. | | | | Read More | | |
| |
| | | | The goals of this program are to foster laboratory, patient-centered and social-behavioral research designed to prevent and relieve the suffering associated with all lung diseases and corresponding risk factors and to fund researchers at important crossroads of their careers to gain long-term commitment to lung disease research. | | | | Read More | | |
| |
| | | | The program supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers. The over-arching goals of the program are to: complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs; enhance the diversity of the biomedical, behavioral and clinical research workforce; help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences; and foster a better understanding of biomedical, behavioral and clinical research and its implications. | | | | Read More | | |
| |
| | | | Selected scholars have access to webinars, resources, come to an in-person retreat to discuss their research project, and are matched with mixed methods expert consultants. | | | | Read More | | |
| |
| | | | The initiative will allocate approximately $210 million in FY2017 and an additional $210 million each year for four years to support additional meritorious early-stage and mid-career investigators. This amount will ramp up over five years to reach approximately $1.1 billion per year. | | | | Read More | | |
| |
| | | | | The statistics research group directed by ISyE associate professor Yajun Mei, is now offering free consulting for data-analysis questions in the domain of bio-related initiatives on the Georgia Tech Campus every Monday in Petit Institute, Room 3317 at 10:30 to 11:30 a.m. during the 2018 fall and 2019 spring semester.
This is the continuation of the consulting sessions offered by Professor Brani Vidakovic, who is taking a leave to work at NSF as a ... | | | | Read More | | |
|
| |
| | | | Please join Georgia Bio's Emerging Leaders Network for a closer look of Boehringer Ingelheim, a global animal health company that provides veterinarians across the region a comprehensive range of products to enhance the health and well-being of a wide range of animals. Formerly known as Merial, and now part of Boehringer Ingelheim, this is a world-leading animal health company that is on the cutting-edge of product development and innovation with a proven track record in producing pharmaceutical products and vaccines for pets, production animals, horses and wildlife. | | | | Read More | | |
| |
| | | | Join Georgia Bio for a networking event to discuss capital raising and the capital markets process, with a focus on due diligence relating to IP, your most important asset as a life sciences company. Jim Corbitt, Intellectual Property Director at Arbor Pharmaceuticals LLC, will provide first-hand experience and insight into this crucial process. | | | | Read More | | |
| |
| | | | The annual award recognizes and celebrates communities that are bringing partners together to improve health for all residents. | | | | Read More | | |
| |
| | | | The U.S. Department of Health and Human Services, Health Resources and Services Administration is soliciting applications for the Health Center Program's Service Area Competition (SAC). The program supports public and private nonprofit community-based and patient-directed organizations that provide primary health care services to the Nation¿s medically underserved. | | | | Read More | | |
| |
| | | | 8th Annual James Reed, MD, Lectureship by Guillermo E. Umpierrez, MD, FACP, FACE, Professor of Medicine, Emory University Section Head, Diabetes & Endocrinology, Grady Health System, at noon in the Grady Trauma Education Auditorium at Grady Hospital. | | | | Read More | | |
| |
| | | | | The K-Club provides an educational forum to assist fellows and faculty. Facilitated by Stacy Heilman, PhD, Assistant Professor, Director, Pediatric Research Operations, Emory University Department of Pediatrics & Children’s Healthcare of Atlanta and presented by Lakshmanan Krishnamurti, MD, Assistant Professor, Director, Pediatric Research Operations, Emory University Department of Pediatrics & Children’s Healthcare of Atlanta.
A light ... | | | | Read More | | |
|
| |
| | | | Presented by Lakshmanan Krishnamurti, MD, Professor, Director of BMT, Chair of Blood and Marrow Transplant, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, at noon in Egleston, Classroom 5. | | | | Read More | | |
| |
| | | | | Presented by David Nash, MD, MBA, Dean, Jefferson College of Public Health, Thomas Jefferson University. Hosted by Emory-Georgia Tech Healthcare Innovation Program and the Georgia CTSA from noon to 2:00 p.m. in Emory School of Medicine auditorium 120. ... | | | | Read More | | |
|
| |
| | | | Since 2013, the NIH Extracellular RNA Communication Consortium (ERCC) has been working to understand the biological functions of extracellular RNAs (exRNAs) and vesicles in the healthy body and in disease. The consortium aims to identify disease biomarkers that can be assayed from biofluids rather than through an invasive biopsy and to develop therapies for disease using exRNA and extracellular vesicles. | | | | Read More | | |
| |
| | | | The webinar is an awareness building training designed to introduce community members to research and the role they can play as partners throughout the process. The Community Engagement team at the BU CTSI created CCR and an accompanying toolkit to facilitate partnerships between researchers, patients, and community members. This webinar will introduce the CCR training toolkit and offer some lessons learned and tips for conducting these trainings with community groups. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
